KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Other Working Capital Changes (2017 - 2026)

Amneal Pharmaceuticals has reported Other Working Capital Changes over the past 9 years, most recently at -$1.0 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 10.06% year-over-year to -$1.0 million; the TTM value through Dec 2025 reached $19.2 million, up 1898.23%, while the annual FY2025 figure was $19.2 million, 1898.23% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$1.0 million at Amneal Pharmaceuticals, down from $10.2 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $115.3 million in Q2 2022 and troughed at -$85.4 million in Q3 2022.
  • A 5-year average of -$279650.0 and a median of -$806000.0 in 2021 define the central range for Other Working Capital Changes.
  • On a YoY basis, Other Working Capital Changes climbed as much as 834.72% in 2022 and fell as far as 2535.58% in 2022.
  • Year by year, Other Working Capital Changes stood at -$5.5 million in 2021, then crashed by 703.01% to -$44.3 million in 2022, then soared by 70.62% to -$13.0 million in 2023, then soared by 91.36% to -$1.1 million in 2024, then rose by 10.06% to -$1.0 million in 2025.
  • Business Quant data shows Other Working Capital Changes for AMRX at -$1.0 million in Q4 2025, $10.2 million in Q3 2025, and $9.5 million in Q2 2025.